ALNY

$156.662.74%-4.42

Pre-market: 157.00+0.34 +0.22%

Alnylam Pharmaceuticals Inc (ALNY)

Alnylam Pharmaceuticals Inc Stock (ALNY) Forecast

The Alnylam Pharmaceuticals Inc (ALNY) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $170.36, representing a +8.75% increase from the current price of $156.66. The highest analyst price target is $185.70, and the lowest is $155.03.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month ALNY Price Target

Average 163.13 (+4.13% Upside)

Is Alnylam Pharmaceuticals Inc (ALNY) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	21.97	Buy
STOCH(9,6)	3.32	Buy
STOCHRSI(14)	4.41	Buy
MACD(12,26)	-20.11	Sell
ADX(14)	25.01	Sell
William %R	-99.20	Buy
CCI(14)	-126.36	Sell

Buy: 4 · Sell: 3 · Neutral: 0Summary: Buy

Moving Averages

Period	Simple	Exponential
MA10	188.55 Sell	181.30 Sell
MA20	208.79 Sell	199.56 Sell
MA50	230.18 Sell	222.31 Sell
MA100	246.96 Sell	244.44 Sell
MA200	281.46 Sell	283.60 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, ALNY could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on ALNY, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 21.97 indicates that ALNY is oversold. This indicates that ALNY price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
STOCH (Stochastic Oscillator): The STOCH value of 3.32 indicates that ALNY is oversold. This indicates that ALNY price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.41 indicates that ALNY is oversold. This suggests that ALNY price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 25.01 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
CCI (Commodity Channel Index): A CCI(14) value of -126.36 indicates that ALNY is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term ALNY price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Alnylam Pharmaceuticals Inc financial reports and earnings history, Alnylam Pharmaceuticals Inc (ALNY) stock could reach $320.36 by 2030, $177.45 by 2040 and $173.26 by 2050. See the projected annual prices until 2050 of the Alnylam Pharmaceuticals Inc stock below:

Alnylam Pharmaceuticals Inc (ALNY) is expected to reach an average price of $229.30 in 2035, with a high prediction of $277.36 and a low estimate of $114.72. This indicates an +46.37% change from the last recorded price of $156.66.
Alnylam Pharmaceuticals Inc (ALNY) stock is projected to chart a bullish course in 2040, with an average price target of $111.48, representing an -28.84% change from its current level. The forecast ranges from a conservative $101.10 to a sky-high $177.45.
Our analysts predict Alnylam Pharmaceuticals Inc (ALNY) to change -22.19% by 2045, soaring from $112.37 to an average price of $121.89, potentially reaching $187.20. While $112.37 is the low estimate, the potential upside is significant.
Alnylam Pharmaceuticals Inc (ALNY) stock is expected to climb by 2050, reaching an average of $133.11, a -15.03% change from its current level. However, a wide range of estimates exists, with high and low targets of $173.26 and $47.13, respectively, highlighting the market's uncertainty.

Alnylam Pharmaceuticals Inc Stock (ALNY) Year by Year Forecast

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2026

The predicted value for Alnylam Pharmaceuticals Inc (ALNY) in 2026 is set at an average of $260.17. Estimates vary from a peak of $427.05 to a trough of $153.23, indicating an +66.07% surge from the present price of $156.66.

Month	Average	Low	High	Change from today's price
December, 2026	$180.17	$155.03	$185.70	+15.01%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Alnylam Pharmaceuticals Inc (ALNY) is $152.25, with a high forecast of $222.77 and a low forecast of $103.49. This indicates an -2.82% decrease from the last price of $156.66.

Month	Average	Low	High	Change from today's price
January, 2027	$122.24	$115.68	$175.82	-21.97%
February, 2027	$136.61	$110.84	$142.94	-12.80%
March, 2027	$140.83	$129.16	$153.54	-10.10%
April, 2027	$155.18	$134.87	$166.24	-0.95%
May, 2027	$120.66	$117.50	$157.74	-22.98%
June, 2027	$111.72	$103.49	$119.21	-28.68%
July, 2027	$133.44	$106.36	$134.19	-14.82%
August, 2027	$129.17	$124.00	$139.95	-17.55%
September, 2027	$201.94	$121.42	$222.77	+28.91%
October, 2027	$209.26	$185.38	$214.04	+33.58%
November, 2027	$171.54	$167.66	$205.63	+9.50%
December, 2027	$194.37	$172.57	$206.36	+24.07%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2028

In 2028, Alnylam Pharmaceuticals Inc (ALNY) is projected to reach an average price of $189.87, with a high projection of $229.03 and a low estimate of $156.08. This indicates an +21.20% rise from the last price of $156.66.

Month	Average	Low	High	Change from today's price
January, 2028	$220.45	$183.25	$221.52	+40.72%
February, 2028	$223.71	$201.33	$229.03	+42.80%
March, 2028	$217.45	$198.71	$228.46	+38.80%
April, 2028	$208.88	$198.80	$220.79	+33.34%
May, 2028	$171.56	$165.30	$204.23	+9.51%
June, 2028	$190.05	$168.42	$197.40	+21.31%
July, 2028	$176.89	$172.41	$198.61	+12.91%
August, 2028	$176.92	$169.15	$181.96	+12.93%
September, 2028	$178.86	$173.83	$191.42	+14.17%
October, 2028	$171.78	$166.22	$205.07	+9.65%
November, 2028	$184.04	$164.85	$186.99	+17.48%
December, 2028	$157.78	$156.08	$198.31	+0.72%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2029

The 2029 price forecast for Alnylam Pharmaceuticals Inc Stock (ALNY) is $162.77 on average, with a high prediction of $261.37 and a low estimate of $128.35. This represents an +3.90% increase from the previous price of $156.66.

Month	Average	Low	High	Change from today's price
January, 2029	$138.01	$137.42	$167.23	-11.90%
February, 2029	$150.00	$134.36	$160.27	-4.25%
March, 2029	$156.33	$142.80	$164.06	-0.21%
April, 2029	$179.70	$155.14	$185.69	+14.70%
May, 2029	$159.38	$155.64	$178.36	+1.74%
June, 2029	$137.43	$129.85	$159.66	-12.28%
July, 2029	$135.81	$130.01	$142.25	-13.31%
August, 2029	$129.68	$128.35	$145.71	-17.22%
September, 2029	$135.79	$129.88	$141.88	-13.32%
October, 2029	$152.11	$133.19	$153.17	-2.90%
November, 2029	$224.26	$195.64	$250.15	+43.15%
December, 2029	$254.69	$217.44	$261.37	+62.57%

Alnylam Pharmaceuticals Inc Stock (ALNY) Price Forecast for 2030

Alnylam Pharmaceuticals Inc Stock (ALNY) is expected to reach an average price of $252.35 in 2030, with a high forecast of $320.36 and a low forecast of $192.47. This signifies an +61.08% surge from the last price of $156.66.

Month	Average	Low	High	Change from today's price
January, 2030	$251.73	$231.34	$274.00	+60.69%
February, 2030	$254.47	$250.84	$266.32	+62.43%
March, 2030	$253.09	$250.15	$290.88	+61.55%
April, 2030	$239.59	$216.37	$273.09	+52.93%
May, 2030	$224.50	$219.94	$244.64	+43.30%
June, 2030	$232.82	$217.54	$248.41	+48.61%
July, 2030	$237.16	$233.18	$273.78	+51.38%
August, 2030	$269.92	$217.37	$276.02	+72.30%
September, 2030	$221.16	$192.47	$287.49	+41.17%
October, 2030	$237.77	$214.89	$264.46	+51.77%
November, 2030	$287.47	$239.41	$296.86	+83.50%
December, 2030	$318.57	$282.46	$320.36	+103.35%

Similar to ALNY